SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-036925
Filing Date
2021-06-01
Accepted
2021-06-01 18:32:10
Documents
2
Period of Report
2021-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3320
2 POA DOCUMENT poa.txt EX-24.3_989307 2127
  Complete submission text file 0001209191-21-036925.txt   6918
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Issuer) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ATHIRA PHARMA, INC. 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address
Worthington Mark (Reporting) CIK: 0001861464 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39503 | Film No.: 21986939